Literature DB >> 6345488

Keynote address: the scientific basis of the present and future practice of clinical radiotherapy.

G H Fletcher.   

Abstract

At mid-century radiotherapy was more an art than a science, but is presently based on radiobiological parameters and cell kinetics. This close interaction between basic scientific principles and clinical practice has been made possible because one can correlate quantitatively doses of irradiation with observed responses. First, a short historical review will be made because it gives a perspective for the understanding both of progress made and prevailing misconceptions. The important radiobiological parameters and cell kinetics will then be discussed in some detail to demonstrate that they should be thoroughly understood in their relationship to radiotherapy. The overall treatment planning must be based on the clinical applications of the main radiobiological parameters. The combined treatment with surgery, either pre- or postoperatively, and multiple daily fractionations will be used as examples. The teaching of radiobiology should be considerably expanded, not only for its own scientific merit but also to show how it applies to clinical situations. This should be reflected in the expansion of the board examination.

Mesh:

Substances:

Year:  1983        PMID: 6345488     DOI: 10.1016/0360-3016(83)90399-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  [The locoregional recurrence of rectal carcinoma. A computed tomographic analysis and a target volume concept for adjuvant radiotherapy].

Authors:  A Bagatzounis; O Kölbl; G Müller; U Oppitz; J Willner; M Flentje
Journal:  Strahlenther Onkol       Date:  1997-02       Impact factor: 3.621

2.  Preoperative radiation therapy for clinically resectable adenocarcinoma of the rectum.

Authors:  W M Mendenhall; R R Million; K I Bland; W W Pfaff; E M Copeland
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

3.  Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLC.

Authors:  Jacob G Scott; Geoff Sedor; Jessica A Scarborough; Michael W Kattan; Jeffrey Peacock; G Daniel Grass; Eric A Mellon; Ram Thapa; Michael Schell; Anthony Waller; Sean Poppen; George Andl; Jamie K Teer; Steven A Eschrich; Thomas J Dilling; William S Dalton; Louis B Harrison; Tim Fox; Javier F Torres-Roca
Journal:  J Thorac Oncol       Date:  2020-12-08       Impact factor: 15.609

4.  Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy.

Authors:  Hyun Ju Kim; Yang-Gun Suh; Yong Chan Lee; Sang Kil Lee; Sung Kwan Shin; Byung Chul Cho; Chang Geol Lee
Journal:  Cancer Res Treat       Date:  2016-10-06       Impact factor: 4.679

5.  High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis.

Authors:  Xin Sun; Lei Wang; Yang Wang; Jingjing Kang; Wei Jiang; Yu Men; Zhouguang Hui
Journal:  Front Oncol       Date:  2020-08-04       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.